Fifth Eye Inc.

Fifth Eye Inc. is a healthcare startup that focuses on averting crises through early awareness of emerging adverse events. The company's flagship product is the AHI System, an FDA-cleared software that predicts episodes of hemodynamic instability with clinically significant lead times, allowing care teams to intervene and avoid costly crises. Founded in 2017 in the United States, the company received a $11.50M Series A investment on 01 April 2019 from investors including Cultivation Capital, Arboretum Ventures, and MINTS. The AHI System, designed for healthcare professionals managing patients over 18 years old, utilizes advanced signal processing, clinician-supervised machine learning, and artificial intelligence to interpret HRV data flow and ECG morphology features, providing crucial insights into patient status. The system's noninvasive nature and ease of adoption make it a valuable addition to hospital telemetry monitoring, enhancing patient care and throughput. Fifth Eye's innovative approach to predictive healthcare technology positions the company as a key player in revolutionizing crisis prevention and patient management.